BIT 4.76% 2.0¢ biotron limited

Corona Virus E Protein as a vaccine target, page-82

  1. pdi
    237 Posts.
    lightbulb Created with Sketch. 29
    There are 306 COVID- 19 related studies globally, 4 in Australia, none of them involves Biotron( to my knowledge).

    Clinicaltrials.gov ( to verify/follow the information)

    Current treatments/trials at a glance:

    The FDA approved the use of chloroquine/hydrochloroquine as treatment despite the absence of well-controlled, large scale clinical data. Gilead is finishing up the remdesivir clinical trials.

    Moderna’s vaccine began testing patients in a Phase I trial on March 16 - ready in 12-14months

    Johnson & Johnson announced the expansion of their existing partnership with BARDA to develop a vaccine for COVID-19. Trials will commence by September, emergency use early 2021. The company plans to market the vaccine on a non-profit bases

    Kiniksa Pharmaceuticals announced that all six COVID-19 patients treated with mavrilimumab in Italy responded to treatment, and three patients were discharged within five days.

    ADMA Biologics received FDA approval for Asceniv, a plasma-based product, primary to treat humoral immunodeficiency disease with the potential to treat COVID




 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.0¢
Change
-0.001(4.76%)
Mkt cap ! $18.94M
Open High Low Value Volume
2.1¢ 2.1¢ 2.0¢ $12.00K 600.2K

Buyers (Bids)

No. Vol. Price($)
1 119306 2.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.1¢ 205783 2
View Market Depth
Last trade - 14.33pm 01/11/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.